Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomized phase 3 BALANCE study
JMG Contact blog,
BALANCE is the first study directly comparing pegunigalsidase alfa with agalsidase beta for the treatment of patients with…